21-羟化酶缺乏症所致先天性肾上腺皮质增生症儿童的睡眠健康评估
该横断面研究在多学科先天性肾上腺皮质增生症(CAH)门诊纳入44例3至18岁经典型CAH患儿,用腕表式活动记录仪佩戴1周并结合经验证的睡眠问卷评估睡眠健康。活动记录仪显示CAH患儿睡眠时长低于推荐指南,睡眠效率更差且入睡后觉醒增加(P < .05);晚间氢化可的松剂量后4至7小时觉醒次数由前2小时的每小时1.67次增至每小时3.12次。作者认为CAH患儿睡眠健康受损,是临床实践和未来研究的重要考虑。
要点
- 44例经典型CAH患儿活动记录仪睡眠时长低于共识推荐指南。
- 与健康儿童相比,CAH患儿睡眠效率更差、入睡后觉醒增加(P < .05)。
- 晚间氢化可的松剂量后4至7小时平均觉醒次数增至每小时3.12次。
核心结论
- 作者认为CAH患儿睡眠健康受损,是临床实践和未来研究的重要考虑。
研究设计与样本
- 横断面研究,在本研究多学科CAH门诊开展。
- 纳入44例3至18岁经典型CAH患儿(23例男性),佩戴ActiGraph GT3X+加速度计1周。
- 儿童与家长完成睡眠问卷,结果与已发表的社区样本及睡眠障碍儿童(临床)样本比较。
主要发现
- 活动记录仪显示CAH患儿睡眠时长低于共识睡眠时长推荐指南。
- 与健康儿童相比,CAH患儿睡眠效率显著更差且入睡后觉醒显著增加(P < .05)。
- 入睡后平均觉醒次数从晚间氢化可的松剂量后前2小时的每小时1.67次增至剂量后4至7小时的每小时3.12次。
- 3至10岁CAH患儿家长报告的入睡延迟显著差于社区样本和临床样本,睡眠时长显著少于两个样本。
- 3至10岁CAH患儿家长报告的夜间觉醒次数显著多于社区样本。
临床怎么用
- 作者认为睡眠健康是CAH患儿临床实践和未来研究的重要考虑。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Literature on sleep health in children with congenital adrenal hyperplasia (CAH) is sparse despite the important role the hypothalamic-pituitary-adrenal axis plays in sleep onset, duration, and awakenings after sleep onset. OBJECTIVE: To evaluate sleep health in children and adolescents with CAH as measured by wrist actigraphy and validated sleep questionnaires. METHODS: Cross-sectional study at our multidisciplinary CAH clinic. Participants aged 3 to 18 years with classic CAH wore an ActiGraph GT3X+ accelerometer for 1 week. Children and parents completed sleep questionnaires, and the results were compared to published samples from the community and children with sleep disorders (clinical). Actigraphy sleep health measures were compared to consensus sleep duration recommendations and normative data in healthy children. RESULTS: Forty-four participants (23 male) with CAH completed the study. Actigraphy found sleep duration in children with CAH was less than recommended guidelines with significantly worse sleep efficiency and increased wake after sleep onset (P < .05) compared to healthy children. After sleep onset, the average number of awakenings increased from 1.67 per hour during the first 2 hours after the evening hydrocortisone dose to 3.12 per hour 4 to 7 hours after the dose, corresponding with washout of the evening hydrocortisone dose. Parents of 3- to 10-year-olds reported significantly worse sleep onset delay and decreased sleep duration than both the community and clinical samples, and significantly more night awakenings than the community sample. CONCLUSION: Our findings suggest that sleep health is impaired in children with CAH and is an important consideration for both clinical practice and future research.
引用
- Golob L, Mercado-Munoz Y, Liu W, et al. Evaluation of Sleep Health in Children With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. J Clin Endocrinol Metab. 2025. PMID: 39607888. doi:10.1210/clinem/dgae836
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。